Technology Prognosis

tracking technologies before you have to make a decision

Inotersen (Ionis-TTRRx)

February 28, 2018

Inotersen is an antisense oligonucleotide (ASO) that inhibits production of transthyretin that is proposed for the treatment of polyneuropathy due to hereditary transthyretin (TTR) amyloidosis.  Inotersen is administered weekly via subcutaneous injection.